Skip to main content

Table 2 (abstract A73). Perioperative data

From: Abstracts of the ICARE 2022 76th SIAARTI National Congress

Overall population

General Anesthesia

Sedation

p-value

(n=124)

(n=62)

(n=62)

 

Operating theatre time, min

363 [300-469]

336 [294-413]

0.04

Surgical time, minute

280[214-365]

266[210-318]

0.257

Number of patients transfused RBC, n (%)

30 (57)

27 (43)

0.589

pH

7.36 [7.33-7.40]

7.31 [7.27-7.38]

0.0001

paO2, mmHg

86 [64-111]

78 [63-101]

0.238

paCO2, mmHg

43 [39-48]

48 [41-57]

0.034

Sodium bicarbonate, mmol/l

22 [20-24]

22 [21-23]

0.681

Base excess, mmol/l

-2.3 [-4.6/-1.2]

-3.8 [-5.2/-1.3]

0.218

Lactate, mmol/l

2 [1.5-2.8]

1.3 [1.1-1.9]

0.0001

Blood losses, ml

400 [200-600]

250 [100-500]

0.027

Inotropes/vasopressors, n (%)

18 (29)

5 (8)

0.002

Vasopressors inotropic score

0 [0-5]

0 [0-0]

0.01

Admission in ICU, n (%)

14 (23)

7 (11)

0.09

ICU, days

0.66 [0-54-1.47]

2.99 [0.73- 8.71]

0.04

Creatinine peak, mg/dl

1.35 [1.03-1.93]

1.33 [1.14-1.62]

0.975

Creatinine clearance, ml/min

49 [32-68]

48 [38-60]

0.848

Surgical conversion, n (%)

1 (2)

0

1

Pulmonary complications, n (%)

12 (19)

11 (18)

0.04

Neurological complications n (%)

3(5)

3(5)

0.631

Cardiac complications, n (%)

8(13)

10(16)

0.360

Spinal cord ischemia, n (%)

7(11)

7(11)

0.694

  1. BSA body surface area; Society for Vascular Surgery/American Association for Vascular Surgery (SVS/AAVS), ASA American Society of Anesthesiologists, EF ejection fraction; Global Initiative for Chronic Obstructive Lung Disease; NYHA New York Heart Association, PTCA percutaneous transluminal coronary angioplasty, CABG coronary artery bypass graft surgery